738.3K XNAS Volume
XNAS 14 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Andrew L. Guggenhime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Scott Braunstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 618,250 | 618,250 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 136,750 | 295,450 | - | 0 | Common Stock | |
| Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 20 Feb 2025 | 3,564 | 431,556 | - | 1.3 | 4,811 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 435,120 | - | 0 | Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 447,066 | - | 0 | Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 20 Feb 2025 | 3,564 | 443,502 | - | 1.3 | 4,811 | Common Stock |
| Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Ruhi Ahmad Khan | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 20 Feb 2025 | 3,564 | 66,936 | - | 1.3 | 4,811 | Common Stock |
| Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 70,500 | - | 0 | Common Stock | |
| Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | |
| Dara Richardson-Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Sriram Ryali | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 29 Jan 2025 | 17,360 | 17,360 | - | 1.4 | 24,651 | Common Stock |
| Sriram Ryali | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 300,000 | 300,000 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 25,000 | 118,854 | - | 0 | Common Stock | |
| O’Byrne V. Jason | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 153,000 | 153,000 | - | - | Option to purchase Common Stock | |
| Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| C. Nancy Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 546,950 | 546,950 | - | - | Option to purchase Common Stock | |
| Haurwitz Rachel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 118,700 | 158,700 | - | 0 | Common Stock | |
| Braunstein Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| McClung G. Barbara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 33,000 | 409,566 | - | 0 | Common Stock | |
| Khan Ruhi Ahmad | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 33,000 | 33,000 | - | 0 | Common Stock | |
| Dara Richardson-Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| G. McClung Barbara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 153,000 | 153,000 | - | - | Option to purchase Common Stock | |
| Johnson L. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Ahmad Khan Ruhi | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 153,000 | 153,000 | - | - | Option to purchase Common Stock | |
| Jason O’Byrne V. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 33,000 | 59,224 | - | 0 | Common Stock | |
| L. Andrew Guggenhime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| B. Steven Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 33,000 | 387,037 | - | 0 | Common Stock | |
| B. Steven Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 153,000 | 153,000 | - | - | Option to purchase Common Stock | |
| B. Kanner Steven | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 30,577 | 21,623 | - | - | Option to purchase Common Stock | |
| B. Kanner Steven | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 06 Feb 2024 | 30,577 | 354,037 | - | 2.7 | 82,252 | Common Stock |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 20 Mar 2023 | 10,000 | 30,000 | - | 3.0 | 29,600 | Common Stock |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2023 | 10,000 | 106,350 | - | - | Option to purchase Common Stock | |
| Andrew L. Guggenhime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Scott Braunstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 510,500 | 510,500 | - | - | Option to purchase Common Stock | |
| Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 131,000 | 131,000 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 131,000 | 131,000 | - | - | Option to purchase Common Stock | |
| Jason V. O’Byrne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 131,000 | 131,000 | - | - | Option to purchase Common Stock | |
| Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 131,000 | 131,000 | - | - | Option to purchase Common Stock | |
| Dara Richardson-Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Syed Ali-aamir Rizvi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 131,000 | 131,000 | - | - | Option to purchase Common Stock | |
| Syed Ali-aamir Rizvi | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 19 Jan 2023 | 5,627 | 59,373 | - | 6.3 | 35,506 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 21,401 | 52,200 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 02 Dec 2022 | 21,401 | 323,460 | - | 2.7 | 57,569 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 2,839 | 1,704 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 06 Oct 2022 | 2,839 | 116,044 | - | 4.1 | 11,668 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 06 Oct 2022 | 2,839 | 113,205 | - | 2.7 | 7,637 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 2,839 | 15,337 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Sale of securities on an exchange or to another person at price $ 10.80 per share. | 06 Oct 2022 | 10,000 | 110,366 | - | 10.8 | 107,958 | Common Stock |
| Barbara G. McClung | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 15 Sep 2022 | 27,518 | 376,566 | - | 2.7 | 74,023 | Common Stock |
| Barbara G. McClung | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 27,518 | 47,318 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 77 | 0 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 15 Sep 2022 | 77 | 349,048 | - | 2.7 | 207 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.22 per share. | 25 Aug 2022 | 43,248 | 302,059 | - | 11.2 | 485,221 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 43,248 | 73,601 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 25 Aug 2022 | 43,248 | 345,307 | - | 2.7 | 116,337 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 4,848 | 120,366 | - | 0 | Common Stock | |
| Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 70,000 | 70,000 | - | - | Option to purchase Common Stock | |
| David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 44,000 | 44,000 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 6,114 | 116,849 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 13 May 2022 | 6,114 | 302,059 | - | 2.7 | 16,447 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.81 per share. | 13 May 2022 | 68,306 | 295,945 | - | 1.8 | 123,634 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 68,306 | 3,534 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 09 May 2022 | 10,000 | 20,000 | - | 3.0 | 29,600 | Common Stock |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 10,000 | 116,350 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,138 | 19,314 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,136 | 5,679 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 15 Mar 2022 | 1,136 | 112,106 | - | 2.7 | 3,056 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 15 Mar 2022 | 1,138 | 113,244 | - | 4.1 | 4,677 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 9,171 | 122,963 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 04 Mar 2022 | 9,171 | 226,090 | - | 2.7 | 24,670 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 1,549 | 230,365 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 04 Mar 2022 | 1,549 | 227,639 | - | 4.1 | 6,366 | Common Stock |
| Jason V. O’Byrne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 08 Feb 2022 | 24,336 | 24,336 | - | 4.1 | 100,021 | Common Stock |
| Jason V. O’Byrne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 24,336 | 412,865 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 10,000 | 126,350 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 26 Jan 2022 | 10,000 | 10,000 | - | 3.0 | 29,600 | Common Stock |
| Syed Ali-aamir Rizvi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 60,000 | 65,000 | - | 0 | Common stock | |
| Syed Ali-aamir Rizvi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 161,250 | 161,250 | - | - | Option to purchase common stock | |
| Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 11 Jan 2022 | 569 | 102,264 | - | 2.7 | 1,531 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | 11 Jan 2022 | 6,818 | 20,452 | - | - | Option to purchase Common Stock | ||
| Ryan Fischesser | VP of Finance and Controller | 11 Jan 2022 | 569 | 6,815 | - | - | Option to purchase Common Stock | ||
| Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 4.11 per share. | 11 Jan 2022 | 6,818 | 109,082 | - | 4.1 | 28,022 | Common Stock |
| Andrew L. Guggenhime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 27,500 | 27,500 | - | - | Option to purchase Common Stock | |
| Scott Braunstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 27,500 | 27,500 | - | - | Option to purchase Common Stock | |
| Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 411,000 | 411,000 | - | - | Option to purchase Common Stock | |
| Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 27,500 | 27,500 | - | - | Option to purchase Common Stock | |
| Steven B. Kanner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 147,000 | 147,000 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 147,000 | 147,000 | - | - | Option to purchase Common Stock | |
| Jason V. O’Byrne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 147,000 | 147,000 | - | - | Option to purchase Common Stock | |
| Ryan Fischesser | VP of Finance and Controller | 20 Dec 2021 | 1,136 | 7,384 | - | - | Option to purchase Common Stock | ||
| Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 20 Dec 2021 | 1,136 | 101,695 | - | 2.7 | 3,056 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 40,000 | 40,000 | - | - | Option to purchase Common Stock | |
| Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 13,060 | 13,060 | - | - | Option to purchase Common Stock | |
| Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 13,750 | 13,750 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 07 Dec 2021 | 6,115 | 348,971 | - | 2.7 | 16,449 | Common Stock |
| Barbara G. McClung | Chief Legal Officer | 07 Dec 2021 | 6,115 | 74,836 | - | - | Option to purchase Common Stock | ||
| Barbara G. McClung | Chief Legal Officer | 07 Dec 2021 | 12 | 77 | - | - | Option to purchase Common Stock | ||
| Barbara G. McClung | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 07 Dec 2021 | 12 | 342,856 | - | 2.7 | 32 | Common Stock |
| Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 225,000 | 225,000 | - | - | Option to purchase Common Stock | |
| Dara Richardson-Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 44,000 | 44,000 | - | - | Option to purchase Common Stock | |
| Barbara G. McClung | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 20 Oct 2021 | 43 | 342,844 | - | 2.7 | 116 | Common Stock |
| Barbara G. McClung | Chief Legal Officer | 20 Oct 2021 | 43 | 89 | - | - | Option to purchase Common Stock | ||
| Barbara G. McClung | Chief Legal Officer | 20 Oct 2021 | 9,176 | 80,951 | - | - | Option to purchase Common Stock | ||
| Barbara G. McClung | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 20 Oct 2021 | 9,176 | 342,801 | - | 2.7 | 24,683 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 12 Oct 2021 | 698 | 200,417 | - | 1.8 | 1,263 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 12 Oct 2021 | 99,548 | 199,719 | - | 1.8 | 180,182 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 12 Oct 2021 | 14,614 | 215,031 | - | 2.7 | 39,312 | Common Stock |
| Steven B. Kanner | Chief Scientific Officer | 12 Oct 2021 | 99,548 | 71,840 | - | - | Option to purchase Common Stock | ||
| Steven B. Kanner | Chief Scientific Officer | 12 Oct 2021 | 698 | 4,879 | - | - | Option to purchase Common Stock | ||
| Steven B. Kanner | Chief Scientific Officer | 12 Oct 2021 | 14,614 | 132,134 | - | - | Option to purchase Common Stock | ||
| Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 11 Oct 2021 | 1,746 | 100,559 | - | 2.7 | 4,697 | Common Stock |
| Ryan Fischesser | VP of Finance and Controller | 11 Oct 2021 | 1,746 | 8,520 | - | - | Option to purchase Common Stock | ||
| Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) |